BPH Diagnosis – Enlarged Prostate is NOT cancer
The renowned interventional oncology specialists of MTVIR want you to know that benign prostatic hyperplasia (BPH), also known as prostate enlargement, isn’t cancer.
However, it can share some symptoms with prostate cancer. As a result, if you’re having uncomfortable symptoms, a proper diagnosis is important. Symptoms such as needing to urinate often, especially at night, weak urine, dribbling or an inability to finish urinating are common in BPH. Some men have no symptoms at all, so regular screening is a good idea.
How is benign prostatic hyperplasia diagnosed?
MTVIR uses a test called PSA, which measures prostate-specific antigens in your blood, as a diagnostic tool. In addition, urine tests, blood tests and a digital rectal exam can help your doctor finalize the diagnosis. If it is still inconclusive, a biopsy, urinary flow tests and a 24-hour voiding diary also provide helpful information to your doctor.
How is BPH treated?
Treatment can include “watchful waiting”, drugs, or minimally invasive treatments. MTVIR offers BPH treatments that are less risky and painful than surgery and require less recovery time. For example, prostate artery embolization is a minimally invasive technique performed under light sedation. A microcatheter is used to deliver a substance that blocks blood flow to the prostate, causing the enlarged tissue to shrink and eventually be reabsorbed by the body.
How to find out more
If your physician has suggested interventional radiology to treat your prostate, contact MTVIR, the leaders in interventional radiology for a consultation. To learn more about MTVIR’s Prostate Artery Embolization (PAE) procedure follow this link Prostate Artery Embolization